CLINICAL_TRIALS
trial_result
· 2021-05-19
Clinical Trial Update: Efficacy and Safety Study of SUNPG1623 [Phase 2]
Summary
Phase 2 clinical trial update for SUNPG1623 in active psoriatic arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Active Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-19